Cleared Traditional

K882401 - STONY BROOK MODEL EECP-MC1

K882401 is an FDA 510(k) clearance for STONY BROOK MODEL EECP-MC1, manufactured by Stony Brook Trading and Development Corp.. The device is a Class 2 Cardiovascular device with product code DRN cleared through the Traditional 510(k) pathway after a 266-day FDA review.

K882401 · Stony Brook Trading and Development Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1989
Decision
266d
Days
Class 2
Risk

K882401 is an FDA 510(k) clearance for the STONY BROOK MODEL EECP-MC1. Classified as Device, Counter-pulsating, External (product code DRN), Class II - Special Controls.

Submitted by Stony Brook Trading and Development Corp. (Northport, US). The FDA issued a Cleared decision on March 3, 1989 after a review of 266 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5225 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Stony Brook Trading and Development Corp. devices

FDA 510(k) Submission Details - K882401

510(k) Number K882401 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 10, 1988
Decision Date March 03, 1989
Days to Decision 266 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
141d slower than avg
Panel avg: 125d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRN Device Classification - Class 2, Special Controls

Product Code DRN Device, Counter-pulsating, External
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.